Home / Brands / Pharmacy Innovations
Pharmacy Innovations Recalls
59 recalls on record · February 1, 2023 to February 1, 2023 · Drugs
February 1, 2023DrugsFDA
Pharmacy Innovations recalls VORICONAZOLE 10MG/ML (10ML DROPPER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls VITAMIN D3-AQUEOUS- 10,000IU/ML (1ML VIAL) INJECTABLE; VITAMIN D3-PF-ETHYL OLEATE- 50,000IU/ML (1ML VIAL) INJECTABLE, Rx
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls VANCOMYCIN FORTIFIED 10MG/ML (1ML DROPTAINER) OPH SOLUTION VANCOMYCIN FORTIFIED 14MG/ML (3ML DROPTAINER) OPH SOLUTION VA
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls TOBRAMYCIN FORTIFIED 15MG/ML OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL 25MG/25MG/25MG/25MG/25MG/20MG/ML (3ML VIAL) INJECTABLE THIAMINE
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls TESTOSTERONE 3% (4GM TUBE) OPHTH OINTME TESTOSTERONE CYP/ANASTROZOLE-GS OIL- 200MG/0.5MG/ML (3.5ML VIAL) INJECTABLE TEST
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls TACROLIMUS 0.03% OPH SOLUTION TACROLIMUS 0.1% (1ML DROPTAINER) OPH SOLUTION TACROLIMUS -CORN OIL- 0.03% OPH SOLUTION T
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls SEMAGLUTIDE 0.5MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 1MG/ML (0.5ML VIAL) INJECTABLE SEMAGLUTIDE 2MG/ML (0.5ML VIAL)
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls SCOPOLAMINE HYDROBROMIDE 0.25% OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls PROSTAGLANDIN (PE1) 45MCG (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 17MCG/ML (1ML VIAL) INJECTABLE PROSTAGLANDIN E1 20MCG/M
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls PROGESTERONE-GS OIL- 100MG/ML (2ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls POLYHEXAMETHYLENE BIGUANIDE 0.2MG/ML (0.2%) (10ML DROPTAINER) OPTH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls POLIDOCANOL 50MG/ML (5%) (30ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACID (10ML VIAL) 50MG/50MG/ML (5%/5%) INJECTABLE; Rx Only, Pharmacy Innovations, 2936 W
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls PHENOL 10% (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls PE1/PAPAV/PHEN 20MCG/30MG/2MG/ML (1ML VIAL) INJECTABLE PE1/PAPAV/PHEN 30MCG/30MCG/2MG/ML (1ML VIAL) INJECTABLE PE1/PAPAV
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls PE1/PAPAV/ATROP/CHLOPROM** 7MCG/8.7MG/0.1MG/1.8MG/ML (1ML VIAL) INJECTABLE PE1/PAPAV/ATROP/CHLORPROM 100MCG/8.7MG/0.1MG/
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls PAPAVERINE/PHENTOLAMINE 30MG/0.5MG/ML (1ML VIAL) INJECTABLE; PAPAVERINE/PHENTOLAMINE 30MG/1MG/ML (1ML VIAL) INJECTABLE;
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls NADH 10MG/ML (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls MITOMYCIN 0.4MG/ML (1ML DROPTAINER) OPH SOLUTION; MITOMYCIN 0.4MG/ML (1ML VIAL) OPH SOLUTION; MITOMYCIN 0.4MG/ML (4ML VI
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls MITOMYCIN 0.2MG/ML (1ML DROPTAINER) OPH SOLUTION; MITOMYCIN 0.2MG/ML (1ML VIAL) OPH SOLUTION, Rx Only, Pharmacy Innovati
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls METHYLCOBALAMIN 12.5MG/ML (1ML VIAL) INJECTABLE METHYLCOBALAMIN 25MG/ML (1.2ML VIAL) INJECTABLE; METHYLCOBALAMIN 3MG/ML
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls METHOTREXATE INTRAVITREAL (1ML VIAL) 4MG/ML (400MCG/0.1ML) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., E
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML (1ML VIAL) INJECTABLE; METHION/INOSIT/CHOLINE/METHYLCOBAL 15MG/5
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls MAGNESIUM CHLORIDE HEXAHYDRATE-PF- 200MG/ML (5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie,
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls LIDOCAINE-PF- 5% (5ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls LEVEMIR-STS- 100U/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls KETAMINE 50MG/ML (10ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls HYDROXOCOBALAMIN-PF- 1MG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
February 1, 2023DrugsFDA
Pharmacy Innovations recalls HEPARIN/LIDO HCL/SODIUM BICARB 100U/2MG/16.8MG/ML (20ML SYRINGE) IRRIGATION, Rx Only, Pharmacy Innovations, 2936 W 17th
Hazard: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.